These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3587183)

  • 1. Relationship between serum vitamin D metabolites and dietary intake of phosphate in patients with early renal failure.
    Tessitore N; Venturi A; Adami S; Roncari C; Rugiu C; Corgnati A; Bonucci E; Maschio G
    Miner Electrolyte Metab; 1987; 13(1):38-44. PubMed ID: 3587183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D3 metabolites in chronic renal failure and after renal transplantation.
    Lucas PA; Woodhead JS; Brown RC
    Nephrol Dial Transplant; 1988; 3(1):70-6. PubMed ID: 3132643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do limited changes in phosphate intake modulate 1,25(OH)2D3 levels in early renal failure?
    Seidel A; Stein G; Schneider S; Schmidt-Gayk H; Ritz E
    Clin Nephrol; 1991 Dec; 36(6):274-80. PubMed ID: 1769138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D metabolites and bone mineralization in man.
    Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
    Portale AA; Booth BE; Halloran BP; Morris RC
    J Clin Invest; 1984 Jun; 73(6):1580-9. PubMed ID: 6547151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on tubular handling of phosphate in hypophosphatemic rickets.
    Alon U; Chan JC
    J Clin Endocrinol Metab; 1984 Apr; 58(4):671-5. PubMed ID: 6546575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure.
    Rix M; Andreassen H; Eskildsen P; Langdahl B; Olgaard K
    Kidney Int; 1999 Sep; 56(3):1084-93. PubMed ID: 10469378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of calcitriol during treatment with protein-reduced diet in patients with renal failure.
    Wilske J; Attman PO
    Nephron; 1994; 66(4):421-5. PubMed ID: 8015645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure.
    St John A; Thomas MB; Davies CP; Mullan B; Dick I; Hutchison B; van der Schaff A; Prince RL
    Nephron; 1992; 61(4):422-7. PubMed ID: 1501739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials.
    de Boer IH; Sachs MC; Chonchol M; Himmelfarb J; Hoofnagle AN; Ix JH; Kremsdorf RA; Lin YS; Mehrotra R; Robinson-Cohen C; Siscovick DS; Steffes MW; Thummel KE; Tracy RP; Wang Z; Kestenbaum B
    Am J Kidney Dis; 2014 Aug; 64(2):187-97. PubMed ID: 24703961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [K/DOQI clinical practice guidelines for management of renal osteodystrophy in predialysis patients].
    Okada N; Tsubakihara Y
    Clin Calcium; 2004 May; 14(5):698-706. PubMed ID: 15577030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Has vitamin D a direct renal effect on the tubular reabsorption of phosphate? A study in parathyroidectomized (PTX) and non-PTX man.
    Madsen S; Olgaard K
    Adv Exp Med Biol; 1978; 103():111-23. PubMed ID: 717102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism.
    Reichel H; Deibert B; Schmidt-Gayk H; Ritz E
    Nephrol Dial Transplant; 1991; 6(3):162-9. PubMed ID: 1866044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-dihydroxycholecalciferol and parathyroid hormone in advanced chronic renal failure: effects of simultaneous protein and phosphorus restriction.
    Lucas PA; Brown RC; Woodhead JS; Coles GA
    Clin Nephrol; 1986 Jan; 25(1):7-10. PubMed ID: 3754187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of protein and phosphate restricted and calcium and alphacalcidol supplemented diet on renal and parathyroid functions and protein status in chronic renal failure patients.
    Nand N; Aggarwal HK; Anupam ; Sharma M
    J Assoc Physicians India; 1999 Sep; 47(9):869-73. PubMed ID: 10778654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vitamin D metabolism in kidney insufficiency: disorders of an endocrine regulatory zone].
    Ritz E; Kreusser W; Boland R; Bommer J
    Klin Wochenschr; 1979 Oct; 57(19):1053-9. PubMed ID: 392179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ionic control of 1,25-dihydroxyvitamin D3 production in isolated chick renal tubules.
    Bikle DD; Rasmussen H
    J Clin Invest; 1975 Feb; 55(2):292-8. PubMed ID: 236326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].
    Offermann G; Schaefer K; Schulz A; Delling G
    Klin Wochenschr; 1976 Jul; 54(13):625-32. PubMed ID: 940299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.